Floatz logo

Monomethyl Fumarate

T-Cell Prolymphocytic Leukemia

Fred Hutchinson Cancer CenterSmall moleculePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

0 Active assets in the T-Cell Prolymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3BB
Cytosin-Arabinosid
M.D. Anderson Cancer Center
Phase 2BB
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2BB
CYCLOSPORIN A
Ohio State University Comprehensive Cancer Center
Phase 3BB
Evomela
Fred Hutchinson Cancer Center
Phase 2BB

View all 12 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →